Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Pricing
Rankings
For Publishers
Log In
Start Free Trial
Naim Shehadeh
Sign up to set email alerts
304
Publications
7,072
Citation Statements Received
8,284
Citation Statements Given
How they've been cited
8,387
345
6,674
53
How they cite others
7,444
647
7,554
83
Affiliations
Rambam Health Care Campus
,
Technion – Israel Institute of Technology
Publications
Order By: Most citations
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Del Prato
1
,
Kahn
2
,
Pavo
3
et al.
2021
The Lancet
710
20
596
1
Get article
Add to collection
Cite
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
le Roux
1
,
Astrup
,
Fujioka
et al.
2017
The Lancet
Abstract
Show
910
15
521
0
4
Get article
Add to collection
Cite
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial
Hansen
1
,
Griffen
2
,
Tschöpe
3
et al.
2017
The Lancet Diabetes & Endocrinology
303
26
380
4
3
Get article
Add to collection
Cite
Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial
Blicher
1
,
Rosenlund
2
,
Hels
3
et al.
2019
The Lancet Diabetes & Endocrinology
Abstract
Show
377
21
357
3
3
Get article
Add to collection
Cite
Liraglutide in Children and Adolescents with Type 2 Diabetes
Tamborlane
1
,
Barrientos Pérez
2
,
Fainberg
3
et al.
2019
N Engl J Med
376
17
342
1
Get article
Add to collection
Cite
Permanent Neonatal Diabetes due to Mutations in
KCNJ11
Encoding Kir6.2
Sagen
1
,
Ræder
2
,
Hathout
3
et al.
2004
Abstract
Show
330
13
285
3
Get article
Add to collection
Cite
Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease
Asleh
1
,
Marsh
,
Shilkrut
3
et al.
2003
Circulation Research
Abstract
Show
254
10
265
2
Get article
Add to collection
Cite
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
Hansen
1
,
Thorén
2
,
Xu
3
et al.
2018
Abstract
Show
249
18
253
3
Get article
Add to collection
Cite
1
2
3